Skip to main content
Acta Endocrinologica (Bucharest) logoLink to Acta Endocrinologica (Bucharest)
. 2021 Jan-Mar;17(1):111–116. doi: 10.4183/aeb.2021.111

Adrenal Myelolipoma Mimics Ectopic Adrenal or Renal Tissue: An Incidental Finding During Cadaveric Dissection

RK Narayan 1,*, A Asghar 1, SK Ghosh 1, S Bharti 2
PMCID: PMC8417488  PMID: 34539918

Abstract

Context.

On naked eye examination adrenal myelolipoma (AML) tissue appears to be an ectopic adrenal or renal tissue, based on the similarity to their external texture. This necessitates a histo-pathological study for confirming the origin of the tissue.

Objective.

To establish the origin and histological features of the incidental AML tissue found during cadaveric dissection and review the literature for similar findings with clinical picture and treatment description.

Subjects and Methods.

Unilateral adrenal gland obtained from cadaveric dissection was subjected to histological study by H & E staining of the slides prepared. The literature review was done from articles published in PubMed indexed journals.

Case report.

A case of an incidental finding of AML during cadaveric dissection is presented which on naked eye examination was appearing to be an ectopic adrenal or renal tissue, based on the similarity to their external texture. On histological examination, a thin rim of adrenocortical tissue, surrounding the mature adipose tissue, and attenuated by islets of myeloid, erythroid and megakaryocytic cell lines in varying proportions, resembling the mature bone marrow morphology, was observed. The literature review on PubMed explains similar incidental post-mortem autopsy findings due to the asymptomatic nature of the tumor. The incidence of AML varied between 0.08% and 0.2% in the last decade of the 20th century, which increased up to 10 – 15% of incidental adrenal masses due to the widespread use of non-invasive imaging modalities leading to an increase in the diagnosis of the pathology.

Conclusions.

Before considering the ectopic incidence of tissue during cadaveric dissection, a histo-pathological examination is mandatory for confirmation. Adreno-myelolipoma is an asymptomatic post-mortem finding in 10-15% of cases of adrenal tissue which mimics ectopic adrenal gland or renal tissue due to its external texture.

Keywords: Adrenomyelolipoma, myeloid, erythroid, megakaryocytic

Introduction

A rare, non-functional, benign neoplasm affecting the adrenal gland with a picture of mature adipose tissue and scattered islands of hematopoietic elements pushing the normal adrenal cortex aside is termed as adrenal myelolipoma or adrenomyelolipoma (1-5). Due to its asymptomatic nature, the diagnosis was made mostly on post-mortem autopsy (3-7). On naked eye appearance, the mass can be confused with an ectopic adrenal or renal tissue based on its similarity to their external texture. Thus, a histological study becomes mandatory to confirm the diagnosis. The era of premortem diagnosis of adrenal myelolipoma can be distinguished from that of the previous incidental detection on autopsy by the prevalent application of imaging modalities like ultrasonography (USG), computed tomography (CT), and magnetic resonance imaging (MRI). Very rarely, but when symptomatic, they present with chronic abdominal pain, and their predominant association with common conditions of obesity, hypertension, diabetes have all been found incidental. The asymptomatic masses do not require any treatment, but those presenting with symptoms of pain due to large size, or those which are prone to rupture and haemorrhage are to be treated by surgical excision of the mass (1-9).

Case presentation

An abnormal enlarged bilobed mass (Fig. 1) was observed above of the left kidney while dissecting an adult female cadaver in the Department of Anatomy, All India Institute of Medical Sciences, Patna. No clinical data were available. On naked eye examination, the texture of the tissue was similar to that of a kidney without the renal capsule and hence the mass was confused with an ectopic adrenal or renal tissue. The tissue was receiving three arterial branches, each one from the inferior phrenic artery, the descending aorta and the left renal artery respectively. The arterial supply proved that the structure must be the adrenal gland. To confirm the tissue origin and the abnormality seen, histopathology was done by making haemotoxylin and eosin slides. The result of the histopathology slides showed a picture of mature fat cells mixed with hematopoietic elements pushing the adrenal tissue, this is homogeneous to the picture seen in adrenal myelolipoma.

Figure 1.

Figure 1.

Bilobed Left adrenal gland in an autopsied sample.

Pathology Findings

The dissected specimen was 4.6 x 2.4 x 1.2 cm in size and weighed 23g. The surface of the mass comprised of a smooth capsule, forming a thin membrane that could be readily peeled off. The mass had rubber like consistency. On gross examination of the section, the mass showed haemorrhagic foci consistent with degenerative tissue. Microscopic examination from the periphery of the tumor revealed a thin rim of adrenocortical tissue surrounding the mature adipose tissue, and attenuated under pressure exerted by the mass. Also islets of myeloid, erythroid and megakaryocytic cell lines were observed in varying proportions, resembling the mature bone marrow morphology. The areas with adipose appearance consisted of mature adipose tissue with haemorrhagic foci (Figs 2a & 2b). Based on the gross and microscopic findings, the diagnosis of myelolipoma was made.

Figure 2 A.

Figure 2 A.

Microscopic section showing hematopoietic cells, fat cells and compressed adrenal cortex (H & E, 10X magnification).

Figure 2 B.

Figure 2 B.

Microscopic section showing hematopoietic cells, fat cells and haemorrhagic foci (H & E, 40X magnification).

Discussion

The first description of adrenal myelolipoma was given by Arnold as “adrenal lipoma” in 1866, description of its myeloid component was given by Gierke in 1905, and the term “formations myelolipomatoses” was coined by Oberling in 1929 (1,2,7). The incidence of adrenal myelolipoma varied between 0.08% and 0.2% in the last decade of the 20th century, which increased up to 10 – 15% of incidental adrenal masses due to the widespread use of non-invasive imaging modalities leading to an increase in diagnosis (10-15).

Adrenal myelolipoma does not have specific sex predilection, though Chen et al. reported the pathology to be predominant in females (9). The incidence is higher in the fifth to seventh decades of life (12-17), though cases with individuals getting afflicted at a young age were also being reported (4, 15). As can be observed from Table 1, the unilateral occurrence is mostly reported on the right side. An interesting relation of laterality was seen in patients afflicted with congenital adrenal hyperplasia (CAH), as most of the bilateral adrenal myelolipoma cases were seen in them, while the unilateral ones were mostly seen to have the left adrenal affected (18). The size of tumour varied from 2 mm to 34 cm. In the literature, the largest myelolipoma by weight (6000 g, diameter 31 cm) was described by Akamatsu et al., and by size (diameter 34 cm, weight 5900 g) was described by Boudreaux et al. Associated conditions such as obesity, CAH, ovarian tumour, hypertension etc., were almost always seen in patients suffering from adrenal myelolipoma, as these conditions were mostly the reason for them to get medical attention in the first place and the radiographic examination led to the incidental diagnosis of adrenal myelolipoma (8, 1819).

Table 1.

Reviews and case reports on adrenal myelolipoma in the 21st century

Author Year No. of cases Age & Sex Laterality Symptoms Associated condition Diagnostic test Treatment
Yildiz et al. 2000 1 54 Y/ F U/L, R Dependent oedema for 2yrs -- CT scan Surgical resection
Lam et al. 2001 11 41 - 81 (M -8; F - 3) U/L, R = 6, L = 5 -- -- Incidental CT/ USG findings = 3; Finding on autopsy = 8 Surgical resection
Osborn et al. 2002 1 47y/ F U/ L, R Frequent urination --  FNAC Follow-up
Bhansali et al. 2003 6 26 - 60 y (M -3; F - 3) U/ L, R = 5, L = 1 2= asymptomatic; 2 = Rt. Flank pain; 1= Oliguria, Anasarca; 1= Headache, sweating, palpitation 4= Obesity + HTN; 1= Obesity + CAH 21 Ohlase deficiency; 1= Obesity CT / MRI 4 = Surgical resection; 2 = Follow- up
Akamatsu et al. 2004 1 51y/ M U/ L, R Huge abdominal mass with pain --  CT/ MRI Surgical resection
Cobanoglu et al. 2005 1 14y/ F U/ L, L Abdomen pain Ovarian Cyst USG Surgical resection
Kalidindi et al. 2006 1 42 y/ M B/ L Obesity, Tanning CAH USG/ CT/ MRI Surgical resection
Nishio et al. 2007 1 38y/ M U/ L, R Rt. Flank pain Spinal cord injury USG/ CT Surgical resection
Song et al. 2008 68 (retrospective) - - --  --  --  CT/ CECT/ MRI -- 
Doddi et al. 2009 1 72y /F U/L, R Dysuria --  USG/ CT/ MRI Surgical resection
Wani et al. 2010 2 52y & 48y/ M U/L, R 1= Abdomen pain; 1= Hypertension 1= Left Bochdalek hernia USG/ CT Surgical resection
Mondal et al. 2011 1 40y/ F U/L, R Rt upper abdomen pain   USG/ CT Surgical resection
Bano et al. 2012 2 1= 65y/ F; 1= 33y/ F U/L, R Rt upper abdomen pain 1= Post- Colecystectomy USG/ CT/ MRI Surgical resection
Yalagachin et al. 2013 1 38y/ F U/L, R Rt upper abdomen pain --  USG/ CT/ MRI Surgical resection
Zorgdrager et al. 2014 3 43 - 60y/ M 1= B/L; 2=U/L, R 1= Abdominal pain, dysuria and haematuria; 2= Rt upper abdomen pain Cholelithiasis, H/O severe trauma USG/ CT/ MRI Surgical resection
Sajjanar et al. 2015 1 58y/ F U/L, R Rt. Flank pain --  USG/ CT/ MRI Surgical resection
Anis-Ul-Islam et al. 2016 1 19y/ M U/L, R Rt. Flank pain  -- CECT Surgical resection
Jeon et al. 2017 1 38y/ F U/L, R --  Breast Carcinoma CT Surgical resection
Manov et al. 2018 1 66y/ F U/L, R  -- Lt. Breast Ca PET - CT Follow-up
Suchartlikitwong et al. 2019 1 39y/ M B/ L  -- Untreated congenital adrenal hyperplasia (CAH) CT Follow-up

Symptoms & associated conditions

Though rarely symptomatic, they present with non-specific abdominal pain, flank pain, anasarca, haematuria, reno-vascular hypertension, and other symptoms secondary to the mechanical compression of adjacent organs (3, 5, 8). Decmann et al. reported prevalence of endocrine disorders in adrenal myelolipoma patients with 10% of their reviewed patients being afflicted with CAH, while the other reported endocrine diseases include Carney’s complex, polycystic ovary syndrome, hyper- or hypothyroidism, Multiple Endocrine Neoplasia syndrome type 1, and Nelson syndrome, but were unlikely to be in real association (20). Surgical emergencies such as retroperitoneal haemorrhage may also be encountered (3).

Pathology

The pathology picture of adrenal myelolipoma presents with adipose tissue and small islands of hematopoietic elements, including the myelocytic, lymphocytic, erythrocytic, and megakaryocytic cells (3-9). Myelolipomas are commonly reported in the adrenal gland, but rare extra-adrenal myelolipomas (EMLs) are also well documented. They have been found in various sites, such as the mediastinum, liver, stomach, lungs, pelvis, spleen, retroperitoneum, pre-sacral region, thoracic spine, and mesentery. EMLs must be distinguished from extramedullary haematopoiesis, which is mainly composed of hematopoietic elements but lacks adipose ones, and is commonly associated with anaemia and marked bone marrow hyperplasia (1, 12).

Radiological findings

The radiographic picture of adrenal myelolipoma on computed tomography depend on its histological composition (10). The mixture of adipose and myeloid tissue lowers the attenuation values to -20 to -30 Hounsfield unit (HU). In about 1/5th of the patients, the capsule may contain calcification which may be related to haemorrhage. The adipose tissue has high intensity on T1- and T2 - weighted sequences of MRI, while the myeloid elements have low intensity on T1 – weighted images and moderate – intensity image on T2 – weighted sequences. Among the three radiographic techniques, USG is the least specific. The tumor appears uniformly hyperechoic if the component is predominantly fatty and hypoechoic if the component is predominantly myeloid. Adrenal myelolipoma is the second most common primary adrenal incidentaloma following adrenocortical adenomas. The other conditions which are required to be differentiated from adrenal myelolipoma (20) are explained in Table 2.

Table 2.

Differential Diagnosis of AML

Differential Diagnosis Pathological findings Radiological findings
Adrenocortical adenomas Well-defined, homogenous, sharply marginated masses. Adenomas are isointense relative to liver and hyper intense relative to spleen on T1 weighted MRI
Adrenocortical carcinomas (ACC) Usually large, heterogeneous with irregular margins, in many cases lobulated tumours, which often have cystic, necrotic or haemorrhagic parts and can invade adjacent structures like the liver, kidney, inferior vena cava. On CECT- Peripheral nodular enhancement is typical.
On T1 weighted MRI, the tumor gives low signal and heterogeneously high signal on T2 weighted sequence.
18FDG-PET can be considered in the differential diagnosis.
Renal angiomyolipoma Most common benign mesenchymal tumor of the kidney, which is composed of mature fat, blood vessels, and smooth muscle cells. It is a large necrotic tumor, and in the majority of the cases it extends through the renal capsule On USG, a homogenously echodense mass can be seen.
CT image gives negative attenuation values. When a fat-containing solid mass growing out of kidney is seen, it is with high probability an angiomyolipoma.
On T1 weighted MRI the tumor is hyperintense relative to the renal parenchyma and isointense relative to fat.
Retroperitoneal liposarcoma Grows slowly, infiltrates the adjacent tissues and rarely gives metastasis. Three grades of aggressiveness are known histologically. The well-differentiated lipogenic type is the most common form and is mostly similar to myelolipoma on radiological images. CECT - Inhomogeneous and not well-demarcated mass is highly similar to myelolipoma
Adrenal lipoma Extremely rare, and diagnosis possible only by histological examination of the removed tumor, as it contains no myeloid elements  

The PubMed search for keyword adrenal myelolipoma shows 884 articles dating back from 1947. A 10-year distribution chart (Fig. 3) shows a steep rise in reporting of myelolipomas in the ninth decade of the 21st century, by nearly 5-times to those in the eighth decade. This rapid shift can be attributed to the increase in utilisation of imaging investigation techniques.

Figure 3.

Figure 3.

Myelolipoma reportings as per PubMed search.

Treatment

The PubMed search also indicated that before the escalated use of radiographic techniques, adrenal myelolipoma was mostly a post-mortem finding and hence treatment of the ailment was seldom reported. But with an increase in diagnostic incidence of this disorder, treatment guidelines were required to be laid and in the absence of such formal guidelines, the management of the condition varies with the individual representation of the tumor. The general approach is surgical resection with follow-up, but if the diagnosis of an adrenal myelolipoma is unambiguous, and no associated symptoms or hormonal activity are established, surgical intervention is usually not necessary (4, 19). However, follow-up of giant myelolipomas (diameter > 10 cm) with USG may be warranted, but the frequency for follow-up is yet to be determined (3, 4).

Hormonal evaluation in adrenal myelolipoma is a debated topic, Shenoy et al. argued for metabolic work-up in patients with adrenal myelolipoma. According to Decmann et al., 18.3% of all adrenal myelolipomas are associated with some kind of endocrine disorder, including congenital adrenal hyperplasia (in 10%), and others like primary aldosteronism, hypercortisolism or hyperandrogenism. The clinical picture should be considered to be the major factor in determining the necessity for hormonal work-up (20).

Being the second most common primary adrenal incidentaloma, adrenal myelolipoma is rarely being diagnosed because of the symptoms of its own. It was mainly a post-mortem finding till the 1980s, a picture which drastically shifted with the escalated use of radiographic diagnostic techniques from the last two decades of the 20th century. Exceptional data has always inflicted the demography of adrenal myelolipoma, such as reports of young individual being diagnosed when it commonly affects individuals in the fifth to seventh decades of life, its size can be as large as 34 cm with maximum weight of 6000 gm reported till date when commonly the size varies from 2-5 mm weighing few grams attributing to its tag of “incidentaloma”.

In conclusion, the benign capsulated nature and lack of adrenal function disturbances in adrenal myelolipoma enables simple surgical resection as a cure, which nowadays is replaced by simple follow-up of the patient in case of absence of any symptoms.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  • 1.Yildiz L, Akpolat I, Erzurumlu K, Aydin O, Kandemir B. Giant adrenal myelolipoma: case report and review of the literature. Pathology international. 2000;50(6):502–504. doi: 10.1046/j.1440-1827.2000.01071.x. [DOI] [PubMed] [Google Scholar]
  • 2.Osborn M, Smith M, Senbanjo T, Crofton M, Robinson S, Rajan P. Adrenal myelolipoma–clinical, radiological and cytological findings: a case report. Cytopathology. 2002;13(4):242–246. doi: 10.1046/j.1365-2303.2002.00357.x. [DOI] [PubMed] [Google Scholar]
  • 3.Bhansali A, Dash RJ, Singh SK, Behra A, Singh P, Radotra BD. Adrenal myelolipoma: profile of six patients with a brief review of literature. Int J Endocrinol Metab. 2003;1:33–40. [Google Scholar]
  • 4.Akamatsu H, Koseki M, Nakaba H, Sunada S, Ito A, Teramoto S, Miyata M. Giant adrenal myelolipoma: report of a case. Surgery today. 2004;34(3):283–5. doi: 10.1007/s00595-003-2682-4. [DOI] [PubMed] [Google Scholar]
  • 5.Cobanoglu U, Yaris N, Cay A. Adrenal myelolipoma in a child. Pediatric surgery international. 2005;21(6):500–502. doi: 10.1007/s00383-005-1394-9. [DOI] [PubMed] [Google Scholar]
  • 6.Kalidindi RS, Hattingh L. Bilateral giant adrenal myelolipomas. Abdominal imaging. 2006;31(1):125–127. doi: 10.1007/s00261-005-0014-4. [DOI] [PubMed] [Google Scholar]
  • 7.Nishio K, Tokiwa S, Saito K, Yoshii T, Ashizawa Y, Kurihara K, Kamiyama Y, Mikata N, Yasuda M, Ide H, Muto S. A case of a giant adrenal myelolipoma in a man with spinal cord injury. Hinyokika kiyo. Acta urologica Japonica. 2007;53(6):387–391. [PubMed] [Google Scholar]
  • 8.Song JH, Chaudhry FS, Mayo-Smith WW. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. American Journal of Roentgenology. 2008;190(5):1163–1168. doi: 10.2214/AJR.07.2799. [DOI] [PubMed] [Google Scholar]
  • 9.Doddi S, Singhal T, Leake T, Sinha P. Management of an incidentally found large adrenal myelolipoma: a case report. Cases journal. 2009;2(1):8414. doi: 10.4076/1757-1626-2-8414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wani NA, Kosar T, Rawa IA, Qayum A. Giant adrenal myelolipoma: Incidentaloma with a rare incidental association. Urology annals. 2010;2(3):130. doi: 10.4103/0974-7796.68865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Mondal SK, Sengupta S, Biswas PK, Sinha MG. Adrenal myelolipoma with abdominal pain: A rare presentation. Indian journal of endocrinology and metabolism. 2011;15(1):57. doi: 10.4103/2230-8210.77589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Bano S, Yadav SN, Chaudhary V, Garga UC. Symptomatic giant adrenal myelolipoma associated with cholelithiasis: Two case reports. Urology annals. 2012;4(1):55. doi: 10.4103/0974-7796.91621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Yalagachin GH, Bhat BK. Adrenal incidentaloma does it require surgical treatment? Case report and review of literature. International journal of surgery case reports. 2013;4(2):192–194. doi: 10.1016/j.ijscr.2012.09.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Zorgdrager M, Pol R, van Hemel B, van Ginkel R. Giant adrenal myelolipoma: when trauma and oncology collide. Case Reports. 2014;2014:bcr2014204023. doi: 10.1136/bcr-2014-204023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Sajjanar AB, Athanikar VS, Dinesh US, Nanjappa B, Patil PB. Non-functional unilateral adrenal myelolipoma, a case report. J Clin Diagn Res. 2015;9(6):ED03–4. doi: 10.7860/JCDR/2015/13209.6070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Anis-Ul-Islam M, Qureshi AH, Zaidi SZ. Adrenal myelolipoma in a young male - a rare case scenerio. J Pak Med Assoc. 2016;66(3):342–344. [PubMed] [Google Scholar]
  • 17.Jeon HJ, Lee SY. A case of adrenal myelolipoma a patient with breast cancer. Acta Endocrinol (Buchar) 2017;13(1):90–95. doi: 10.4183/aeb.2017.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Manov JJ, Diaz-Bode A, Kuker R. Hematopoietically active adrenal myelolipoma mimicking breast cancer metastasis. Clin Nucl Med. 2018;43(8):602–603. doi: 10.1097/RLU.0000000000002144. [DOI] [PubMed] [Google Scholar]
  • 19.Suchartlikitwong S, Jasti R, Lado-Abeal J, Rivas Mejia AM. Bilateral adrenal myelolipomas presenting as acute adrenal insufficiency in an adult with congenital adrenal hyperplasia. BMJ Case Rep. 2019;12(2) doi: 10.1136/bcr-2018-226826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Decmann Á, Perge P, Tóth M, Igaz P. Adrenal myelolipoma: a comprehensive review. Endocrine. 2018;59(1):7–15. doi: 10.1007/s12020-017-1473-4. [DOI] [PubMed] [Google Scholar]

Articles from Acta Endocrinologica (Bucharest) are provided here courtesy of Acta Endocrinologica Foundation

RESOURCES